Enzalutamide treatment sensitivity recovery effect of docetaxel treatment after relapse of enzalutamide treatment for castration-resistant prostate cancer patients
Not Applicable
- Conditions
- Castration-resistant prostate cancer
- Registration Number
- JPRN-UMIN000019325
- Lead Sponsor
- Department of Urology Uonuma Institute of Community Medicine Niigata University Medical and Dental Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients treated by chemotherapy 2. Patients judged to be inappropriate to perform this study by investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Biochemical-free survival rate (Prostate specific antigen progression free survival rate (PSA-PFS)) after enzalutamide retreatment
- Secondary Outcome Measures
Name Time Method